AJP - Heart and Circulatory Physiology, Vol 271, Issue 3 1087-H1093, Copyright © 1996 by American Physiological Society

ARTICLES

Acidic and basic FGFs dilate arterioles of skeletal muscle through a NO-dependent mechanism

H. M. Wu, Y. Yuan, M. McCarthy and H. J. Granger
Microcirculation Research Institute, Texas A & M University Health Science Center, Temple 76504, USA.

Fibroblast growth factors (FGFs) have been known to be potent stimulators of vascular endothelial cell proliferation and angiogenesis. Recent experimental evidence indicates that basic FGF (bFGF) is also involved in modulation of arterial pressure. In this study, we investigated the effects of acidic FGF (aFGF) and bFGF on muscle microcirculation using isolated arterioles and intact cremaster muscles of the at. In isolated microvessels, aFGF and bFGF (10(-12)-10(-8) M) significantly increased arteriolar diameter in a dose-dependent and time-dependent manner. This effect was abolished during inhibition of nitric oxide synthesis by NG-monomethyl-L-arginine (L-NMMA, 10(-4) M) but was not affected by indomethacin (10(-4) M), an inhibitor of the cyclooxygenase pathway of arachidonic acid metabolism. The vasodilation induced by FGFs was not observed in endothelium-denuded vessels. Furthermore, we studied microvascular hemodynamics in response to the growth factors in the cremaster muscle using intravital microscopy. Both aFGF and bFGF dilated arterioles of the intact cremaster muscle in a pattern similar to that observed in the isolated arterioles. At a concentration of 10(-10) M, aFGF caused a 19% increase in vessel diameter and 56% increase in blood flow. Administration of L-NMMA blocked by FGF-induced vasodilation and hyperemia. These results suggest that FGFs modulate blood flow in the skeletal muscle by acting on the endothelium of arterioles. The signaling mechanism of FGF-induced vasodilation involves the synthesis of nitric oxide by arteriolar endothelium.

This article has been cited by other articles:

				T. Shoji, Y. Yonemitsu, K. Komori, M. Tanii, H. Itoh, S. Sata, H. Shimokawa, M. Hasegawa, K. Sueishi, and Y. Maehara Intramuscular gene transfer of FGF-2 attenuates endothelial dysfunction and inhibits intimal hyperplasia of vein grafts in poor-runoff limbs of rabbit Am J Physiol Heart Circ Physiol, June 5, 2003; 285(1): H173 - H182. [Abstract] [Full Text] [PDF]

				S. R. Wedge, D. J. Ogilvie, M. Dukes, J. Kendrew, R. Chester, J. A. Jackson, S. J. Boffey, P. J. Valentine, J. O. Curwen, H. L. Musgrove, et al. ZD6474 Inhibits Vascular Endothelial Growth Factor Signaling, Angiogenesis, and Tumor Growth following Oral Administration Cancer Res., August 15, 2002; 62(16): 4645 - 4655. [Abstract] [Full Text] [PDF]

				J. P. Cooke and D. W. Losordo Nitric Oxide and Angiogenesis Circulation, May 7, 2002; 105(18): 2133 - 2135. [Full Text] [PDF]

				P. G. Lloyd, H. T. Yang, and R. L. Terjung Arteriogenesis and angiogenesis in rat ischemic hindlimb: role of nitric oxide Am J Physiol Heart Circ Physiol, December 1, 2001; 281(6): H2528 - H2538. [Abstract] [Full Text] [PDF]

				S. E. Epstein, R. Kornowski, S. Fuchs, and H. F. Dvorak Angiogenesis Therapy : Amidst the Hype, the Neglected Potential for Serious Side Effects Circulation, July 3, 2001; 104(1): 115 - 119. [Full Text] [PDF]

				T. Yamamoto and R. J. Bing Nitric Oxide Donors Experimental Biology and Medicine, December 1, 2000; 225(3): 200 - 206. [Abstract] [Full Text]

				Q. Huang, M. Wu, C. Meininger, K. Kelly, and Y. Yuan Neutrophil-dependent augmentation of PAF-induced vasoconstriction and albumin flux in coronary arterioles Am J Physiol Heart Circ Physiol, October 1, 1998; 275(4): H1138 - H1147. [Abstract] [Full Text] [PDF]